These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7724997)

  • 1. Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapy.
    Doria A; Ghirardello A; Boscaro M; Viero ML; Vaccaro E; Patrassi GM; Gambari PF
    Rheumatol Int; 1995; 14(5):207-11. PubMed ID: 7724997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis.
    Salazar-Paramo M; Garcia de la Torre I; Fritzler MJ; Loyau S; Anglés-Cano E
    Lupus; 1996 Aug; 5(4):275-8. PubMed ID: 8869898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.
    Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Miyajima Y; Kazama M
    Acta Haematol; 1992; 88(4):189-93. PubMed ID: 1337960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and analysis of the multimeric structure of von Willebrand factor (vWF).
    Kagawa H; Okubo S; Yasunaga K
    Int J Hematol; 1991 Oct; 54(5):429-39. PubMed ID: 1756253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of osteonecrosis in systemic lupus erythematosus with abnormalities of fibrinolysis.
    Sheikh JS; Retzinger GS; Hess EV
    Lupus; 1998; 7(1):42-8. PubMed ID: 9493148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Díaz-Gomez F; Pacheco-Pantoja E; Drenkard C; Alarcón-Segovia D
    Am J Hematol; 1991 May; 37(1):9-13. PubMed ID: 1902623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus.
    Keeling DM; Campbell SJ; Mackie IJ; Machin SJ; Isenberg DA
    Br J Haematol; 1991 Mar; 77(3):354-9. PubMed ID: 1707291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibodies to distinct epitopes of the tissue-type plasminogen activator (t-PA) in patients with systemic lupus erythematosus.
    Ruiz-Arguelles A; Angles-Cano E; Perez-Romano B; Ruiz-Arguelles GJ; Deleze M; Alarcon-Segovia D; Gaussem P
    Am J Hematol; 1995 Jun; 49(2):109-14. PubMed ID: 7539580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of the venous occlusion test on systemic lupus erythematosus patients with a focus on changes in blood levels of tissue plasminogen activator, von Willebrand factor antigen, and thrombomodulin.
    Matsuda J; Kawasugi K; Gohchi K; Saitoh N; Tsukamoto M; Kazama M; Kinoshita T
    Acta Haematol; 1992; 88(1):22-6. PubMed ID: 1329422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
    Caccavo D; Del Porto F; Garzia P; Mitterhofer AP; Galluzzo S; Rigon A; Vadacca M; Navajas MF; Amoroso A; Afeltra A
    Ann Rheum Dis; 2003 Oct; 62(10):1003-5. PubMed ID: 12972482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
    Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
    Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis.
    Awada H; Barlowatz-Meimon G; Dougados M; Maisonneuve P; Sultan Y; Amor B
    J Lab Clin Med; 1988 Feb; 111(2):229-36. PubMed ID: 3123585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. t-PA, PAI, and protein C before and after vascular occlusion of the upper limb in patients with Raynaud's phenomenon.
    Cimminiello C; Milani M; Uberti T; Arpaia G; Motta A; Bonfardeci G
    Angiology; 1991 Mar; 42(3):231-8. PubMed ID: 1902068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.
    Lau CS; McLaren M; Mackay I; Belch JJ
    Ann Rheum Dis; 1993 Jun; 52(6):443-8. PubMed ID: 8323396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes to fibrinolysis in patients with systemic lupus erythematosus are associated with endothelial cell damage and inflammation, but not antiphospholipid antibodies.
    Dhillon PK; Khalafallah AA; Adams MJ
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):870-875. PubMed ID: 27167859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of early endothelial damage in patients with Raynaud's phenomenon.
    Gualtierotti R; Ingegnoli F; Griffini S; Grovetti E; Borghi MO; Bucciarelli P; Meroni PL; Cugno M
    Microvasc Res; 2017 Sep; 113():22-28. PubMed ID: 28450106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.